RxDoctor Payments Data

Carlos Lavernia, MD

Adult Reconstructive Orthopaedic Surgery · Miami, FLNPI 1255326179

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $5,361,788 of the $5,446,311 with a category attached, or 98.4%. Stryker accounts for 100.0% of it on its own, with 5 other manufacturers making up the rest. Among adult reconstructive orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,446,311in general payments, 2019–2025

Across 113 payments — averaging $48,197 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$5.4M
  • Intellijoint Surgical Inc.$750
  • Smith+Nephew$148
  • Zimmer Biomet$148
  • Pacira Pharmaceuticals Incorporated$122
  • Amgen$121

What the payments were for

  • Royalty or licence$5,361,78898%
  • Consulting fees$79,8751%
  • Travel & lodging$3,0050%
  • Food & beverage$1,6430%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,446,311 in reported general payments places this provider in the 95th percentile of 96 adult reconstructive orthopaedic surgery providers in Florida.

See all adult reconstructive orthopaedic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$120,071
Medicare patients
199
Services billed
1,187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib96$3,156
Ondansetron Hcl82$654
Tramadol Hcl84$627
Omeprazole76$378
Oxycodone Hcl76$343
Cefadroxil43$307
Cephalexin16$122
Ciprofloxacin Hcl14$114
Lorazepam70$103
Meloxicam27$27

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →